Prior to publication of the final evidence report, EPCs sought input from independent Peer Reviewers without financial conflicts of interest. However, the conclusions and synthesis of the scientific literature presented in this report do not necessarily represent the views of individual reviewers.

Peer Reviewers must disclose any financial conflicts of interest greater than $10,000 and any other relevant business or professional conflicts of interest. Because of their unique clinical or content expertise, individuals with potential nonfinancial conflicts may be retained. The TOO and the EPC work to balance, manage, or mitigate any potential nonfinancial conflicts of interest identified.

The list of Peer Reviewers follows:

• Ingeborg A. Brouwer, Ph.D., M.Sc.
  Vrije Universiteit Amsterdam
  Amsterdam, The Netherlands
• David A. Lathrop, Ph.D.
  National Institutes of Health
  National Heart, Lung and Blood Institute
  Washington, DC
• JoAnn E. Manson, M.D., M.P.H., Dr.P.H.
  Harvard Medical School
  Harvard T.H. Chan School of Public Health
  Brigham and Women’s Hospital
  Boston, MA
• Hildegard Przyrembel, M.D., Ph.D.
  Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment)
  Berlin, Germany